Lemtrada

Lemtrada Drug Interactions

alemtuzumab

Manufacturer:

Genzyme

Distributor:

DKSH
Full Prescribing Info
Drug Interactions
No formal drug interaction studies have been conducted with LEMTRADA using the recommended dose in patients with MS. In a controlled clinical trial in MS patients recently treated with beta interferon and glatiramer acetate were required to discontinue treatment 28 days before initiating treatment with LEMTRADA.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in